Linda Beer, PhD, on Cost as a Barrier to ART Adherence
In this podcast,\xa0Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of\xa0US surveillance data of adults with HIV infection that examined the financial barriers to antiretroviral therapy adherence. More at: www.consultant360.com/infectious-diseases.